基本信息
views: 88
Career Trajectory
Bio
Prof Hogg has made novel, small-molecule inhibitors of mitochondrial adenine nucleotide translocase (ANT), GSAO and PENAO, that are currently being trialled in patients with solid tumours. Cystemix Pty Ltd was formed to manage the commercial development of this suite of drugs. Prof Hogg has invented an effective small molecule non-invasive imaging agent for dying and dead cells. This technology will have many applications both in the research arena and in clinical practice. Its most obvious clinical utility is for monitoring cancer therapy.
Research Interests
Papers共 300 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of thrombosis and haemostasis : JTHno. 8 (2023): 2089-2100
Venessa Chin, Himanshi Arora,Jose Alquicira-Hernandez, Anne Sennabouth,Rachael McCloy,John Simes,Michael Boyer,Philip Hogg,Jane Young,Anthony Joshua,Bea Brown,Joseph Powell
Cited0Views0Bibtex
0
0
Jianhua Wang,Jincheng Wang,Jinlu Dai,Younghun Jung, Chuen-Long Wei,Yu Wang,Aaron M. Havens,Phillip J. Hogg,Evan T. Keller,Kenneth J. Pienta,Jacques E. Nor,Cun-Yu Wang,
crossref(2023)
Nuclear medicine and biology (2023): 108380-108380
Circulation research (2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn